An evaluation of motor evoked potential surrogate endpoints during intracranial vascular procedures

R N Holdefer1, D B MacDonald2, L Guo3

  • 1Department of Rehabilitation Medicine, University of Washington School of Medicine, Box 359740, Seattle, WA 98104-2499, USA.

Abstract

Insights

Motor Evoked Potentials (MEPs) effectively predict intervention success in preventing postoperative deficits during intracranial vascular surgery. Recovering MEP decline correlates with preserved neurological function, supporting their role as surrogate endpoints.

Area of Science:

  • Neurosurgery
  • Neurology
  • Clinical Trials

Background:

  • Motor Evoked Potentials (MEPs) are utilized as surrogate endpoints to assess the efficacy of interventions aimed at preventing new postoperative deficits.
  • Investigating MEP performance in capturing intervention effects on these outcomes is crucial for surgical decision-making.

Purpose of the Study:

  • To evaluate the effectiveness of MEPs as surrogate endpoints in intracranial vascular surgeries.
  • To determine the diagnostic performance of MEPs and their correlation with postoperative deficits.

Main Methods:

  • A meta-analysis of studies published between 2003 and 2014 involving MEPs during intracranial vascular surgeries.
  • Assessed MEP diagnostic performance and the relative risk of new postoperative deficits for reversible versus irreversible MEP changes.
  • Compared intervention efficacy in reversing MEP deterioration and subsequent postoperative outcomes.

Main Results:

  • MEP diagnostic performance was favorable, with likelihood ratios exceeding 10.
  • Reversible MEP changes were associated with a 60% reduction in new postoperative deficits (relative risk = 0.40).
  • A significant negative correlation (r=-0.81, p<.005) was found between MEP recovery and the incidence of new postoperative deficits.

Conclusions:

  • Intervention effectiveness in reversing MEP decline predicts preserved neurological status.
  • MEPs are provisionally qualified as surrogate endpoints due to their predictive value and minimal associated harms/costs.
  • MEPs demonstrated reliable performance as surrogate endpoints for motor strength deficits in the immediate postoperative period following intracranial vascular surgery.

Related Concept Videos